Does Mounjaro Prevent Pregnancy — and What Should You Know Before Starting?

What NHS England and the MHRA guidance says about contraception on Mounjaro

Official UK guidance is clear: women of childbearing potential should use effective contraception while taking tirzepatide. This comes directly from NHS England's wraparound care guidance on weight-management injections, which specifically addresses oral contraceptive pills and Mounjaro in the same breath.

The reason is pharmacological rather than precautionary box-ticking. Mounjaro slows gastric emptying, which means anything absorbed from the gut (including the hormones in a combined or progestogen-only pill) may be absorbed more slowly or less completely than usual. For the first four weeks of treatment, and again for four weeks after each dose increase, women taking oral contraceptives are advised to add a non-oral method such as condoms. A contraceptive patch, implant, injection or coil avoids the absorption question altogether and may be a simpler long-term solution; that is worth discussing with a GP or prescriber before starting.

There is no equivalent absorption warning for semaglutide (Wegovy), which the same NHS guidance notes separately. This distinction matters if you are comparing the two medicines or considering switching. A question our prescribers hear most weeks is whether existing contraception is "enough" when starting Mounjaro, the honest answer is that it depends which type you use, so always confirm with whoever manages your contraception.

Mounjaro does not prevent pregnancy, but weight loss can change fertility

Tirzepatide has no hormonal contraceptive properties. It does not suppress ovulation, alter the uterine lining, or act on the reproductive system directly. If pregnancy occurs while someone is taking Mounjaro, it will not have been because the medicine failed as a contraceptive, there was no contraceptive action to fail.

What Mounjaro does do, for many people, is produce significant weight loss. And meaningful weight reduction can itself restore ovulatory cycles in women who had irregular or absent periods due to excess weight, insulin resistance, or PCOS. For women who assumed their reduced fertility was a reliable form of protection, this is clinically important. The Mounjaro, PCOS and pregnancy page looks at this in more depth, but the short version is: do not assume irregular cycles on Mounjaro mean you cannot conceive. They may well normalise as treatment progresses.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled over 2,500 adults and documented the magnitude of weight loss tirzepatide can achieve. Improved metabolic and hormonal function follows weight loss, and reproductive function is part of that picture. The clinical implication is that reliable contraception becomes more important once treatment is underway, not less.

Stopping Mounjaro before trying for a pregnancy

If you are planning a pregnancy, the guidance is to stop tirzepatide and allow time before trying to conceive. The MHRA advises a wash-out period, though the exact duration should be confirmed with your prescriber rather than inferred from general articles, the SmPC is the definitive reference, and individual circumstances vary.

Mounjaro is not recommended in pregnancy. Animal studies raised concerns that are sufficient for regulators to advise against use, and human data in pregnancy is limited. The precautionary position is to stop well before conception rather than at a positive test. If you become pregnant while taking Mounjaro, contact your prescriber and GP promptly. Similarly, breastfeeding while on tirzepatide is not recommended. Under-18s are outside the licensed indication entirely.

If you are currently on Mounjaro and thinking about having children in the next year or two, the right conversation is with your GP or prescriber now, not when a pregnancy test turns positive. The pregnancy and tirzepatide page sets out what the current evidence base looks like, and our clinical team can address this during any consultation. For practical questions about what happens after a pregnancy, the Mounjaro after pregnancy guide is a useful next read.

How to raise this at your consultation

The questions to bring to any prescriber are: which contraceptive method you currently use, whether you want to conceive in the foreseeable future, and whether your cycles have already been irregular. Each of those affects the advice you receive. The Mounjaro treatment page outlines the full eligibility picture, and if you are weighing up the broader treatment options, speaking to our prescribers is a good place to start. The effects of Mounjaro on an existing pregnancy is a separate question covered elsewhere, as is the specific topic of Mounjaro and the menopause for those at a different life stage. If you have more general questions before getting started, the FAQs page covers the most common ones. Suspect side effects at any point can be reported directly to the MHRA via the Yellow Card scheme.